Logo Image
|Articles|January 24, 2023

One Week Left for CTIS Mandatory Use Date

EMA reminds the clinical trials community that the Clinical Trials Information System will be mandatory at the last day of this month.

On January 31, 2023, the use of the Clinical Trials Information System (CTIS) will become mandatory for new clinical trials applications and will serve as the single-entry point for submission by sponsors and for regulatory assessment. The EMA reiterated this deadline and updated the community on the current status of the system, which has been in transition for one year.

Read additional information from the EMA.

Related to this article

View more
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain how ICH E6(R3) and new empirical evidence of RBQM's net financial impact give sponsors the tools they need to build the multi-functional buy-in required for successful adoption—and why RBQM only delivers full value when it replaces, not supplements, traditional monitoring.
Read more
© ABCDstock - © ABCDstock - stock.adobe.com
Beyond Patient Centricity: What Rare Disease Research Gets Right
Patient-centricity remains largely consultative in most clinical research, yet rare disease communities demonstrate that genuine partnership from protocol inception improves feasibility, reduces unnecessary burden, and identifies outcomes that matter to patients themselves.
Read more